The company's high P/E ratio is backed by anticipated robust...
The company's high P/E ratio is backed by anticipated robust future growth, surpassing the broader market. Investors appear to dismiss the possibility of a substantial earnings decline, thus not justifying a lower P/E ratio. Hence, a significant drop in share price seems unlikely soon.
Hvsen Biotechnology Co., Ltd.'s (SZSE:300871) 30% Jump Shows Its Popularity With Investors
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment